Skip to content

Jobs updated Oct 23, 6:25 AM CT

COMPANY

Starlight Therapeutics

HQ: Plano, TX source · starlightthera.com ↗ · Southwest

Clinical Phase 2

Keywords: neurology oncology Glioblastoma

Location: Plano, TX · source · Oct 15, 2026

Profile checked Oct 10, 2026

1Trials (company is sponsor)

Timeline

May 1, 2026 Trial start 1: A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression source ↗

Upcoming milestones

May 1, 2027 (ESTIMATED) · 1 · A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression · NCT07431216

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT07431216	A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression	1	Not yet recruiting	May 1, 2026	May 1, 2027 (estimated)